Bernardo, Judith R.

HRN: 22-55-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2023
02/08/2023
IV
500mg
Q8
Perianal Abscess
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: No  Wrong Dose  Increase To Q6

Overall appropriateness: No  Increase To Q6

Intervention



Type of Intervention done:

                    

           


Acceptance: